RICHARD ERIC ATANGAN: Open Payments
NPI 1871245688 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 21 payments from 7 companies in 2025. Trend: 2023 $1,108 · 2024 $1,006 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 8 | $369 |
| AstraZeneca Pharmaceuticals LP | 3 | $169 |
| AKEBIA THERAPEUTICS INC | 5 | $101 |
| Fresenius USA Marketing, Inc. | 2 | $43 |
| Novo Nordisk Inc | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Medtronic, Inc. | 1 | $14 |
Products named: IBSRELA, LOKELMA, XPHOZAH 30 MG, Vafseo, VELPHORO, Ozempic, Kerendia, ELLIPSYS VASCULAR ACCESS SYSTEM.
Industry payments across CA — which companies pay providers there.
